Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,920 DKK | -0.72% | -6.55% | -10.88% |
05-21 | Genmab A/S Reaffirms Financial Guidance for 2024 | CI |
05-21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.88% | 18.18B | |
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B | |
-30.06% | 7.6B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Danish Biotech Genmab Lifts FY22 Forecast Anew On Continued Darzalex Boost